Status
Conditions
Treatments
About
This is a single patient expanded access, compassionate and non-emergency use study that provides patients with severe asthma, who do not qualify for ongoing clinical trials with dupilumab, access to this investigational treatment.
Full description
This study is being undertaken to determine whether dupilumab has efficacy in extremely severe asthma, and to allow a very severe asthma patient, who has been tried on nearly every immunosuppressive drug, early access to a potentially effective therapy.
The patient will continue in the study indefinitely. Safety will be evaluated and serious adverse events will be reported.
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
This is a single-patient study. The University of Pittsburgh site is not enrolling new patients.
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal